Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnesium sulfate is an inorganic salt used as a medication and supplement. It is primarily indicated for the treatment and prevention of low blood magnesium (hypomagnesemia), control of seizures in pre-eclampsia and eclampsia, management of acute nephritis in children, as a laxative for short-term relief of constipation, and as a soaking solution to relieve minor sprains, bruises, muscle aches or discomfort. Mechanistically, it acts by reducing acetylcholine release at the neuromuscular junction—thereby decreasing striated muscle contractions—and by direct inhibition of action potentials in myometrial muscle cells. It also plays an essential role in many enzyme systems involved with neurochemical transmission and muscular excitability[1][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium sulfate.